Literature DB >> 22568499

Nociceptive neuropeptide increases and periorbital allodynia in a model of traumatic brain injury.

Melanie B Elliott1, Michael L Oshinsky, Peter S Amenta, Olatilewa O Awe, Jack I Jallo.   

Abstract

OBJECTIVE: This study tests the hypothesis that injury to the somatosensory cortex is associated with periorbital allodynia and increases in nociceptive neuropeptides in the brainstem in a mouse model of controlled cortical impact (CCI) injury.
METHODS: Male C57BL/6 mice received either CCI or craniotomy-only followed by weekly periorbital von Frey (mechanical) sensory testing for up to 28 days post-injury. Mice receiving an incision only and naïve mice were included as control groups. Changes in calcitonin gene-related peptide (CGRP) and substance P (SP) within the brainstem were determined using enzyme-linked immunosorbent assay and immunohistochemistry, respectively. Activation of ionized calcium-binding adaptor molecule-1-labeled macrophages/microglia and glial fibrillary acidic protein (GFAP)-positive astrocytes were evaluated using immunohistochemistry because of their potential involvement in nociceptor sensitization.
RESULTS: Incision-only control mice showed no changes from baseline periorbital von Frey mechanical thresholds. CCI significantly reduced mean periorbital von Frey thresholds (periorbital allodynia) compared with baseline and craniotomy-only at each endpoint, analysis of variance P < .0001. Craniotomy significantly reduced periorbital threshold at 14 days but not 7, 21, or 28 days compared with baseline threshold, P < .01. CCI significantly increased SP immunoreactivity in the brainstem at 7 and 14 days but not 28 days compared with craniotomy-only and controls, P < .001. CGRP levels in brainstem tissues were significantly increased in CCI groups compared with controls (incision-only and naïve mice) or craniotomy-only mice at each endpoint examined, P < .0001. There was a significant correlation between CGRP and periorbital allodynia (P < .0001, r = -0.65) but not for SP (r = 0.20). CCI significantly increased the number of macrophage/microglia in the injured cortex at each endpoint up to 28 days, although cell numbers declined over weeks post-injury, P < .001. GFAP(+) immunoreactivity was significantly increased at 7 but not 14 or 28 days after CCI, P < .001. Craniotomy resulted in transient periorbital allodynia accompanied by transient increases in SP, CGRP, and GFAP immunoreactivity compared with control mice. There was no increase in the number of macrophage/microglia cells compared with controls after craniotomy.
CONCLUSION: Injury to the somatosensory cortex results in persistent periorbital allodynia and increases in brainstem nociceptive neuropeptides. Findings suggest that persistent allodynia and increased neuropeptides are maintained by mechanisms other than activation of macrophage/microglia or astrocyte in the injured somatosensory cortex.
© 2012 American Headache Society.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22568499      PMCID: PMC4105160          DOI: 10.1111/j.1526-4610.2012.02160.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  82 in total

1.  Neuroinflammatory responses after experimental diffuse traumatic brain injury.

Authors:  Brian Joseph Kelley; Jonathan Lifshitz; John Theodore Povlishock
Journal:  J Neuropathol Exp Neurol       Date:  2007-11       Impact factor: 3.685

2.  Essential protective roles of reactive astrocytes in traumatic brain injury.

Authors:  D J Myer; G G Gurkoff; S M Lee; D A Hovda; M V Sofroniew
Journal:  Brain       Date:  2006-07-05       Impact factor: 13.501

3.  Differential behavioral and histopathological responses to graded cortical impact injury in mice.

Authors:  Kathryn E Saatman; Kristofer J Feeko; Rebecca L Pape; Ramesh Raghupathi
Journal:  J Neurotrauma       Date:  2006-08       Impact factor: 5.269

4.  Acute effects of a selective cannabinoid-2 receptor agonist on neuroinflammation in a model of traumatic brain injury.

Authors:  Melanie B Elliott; Ronald F Tuma; Peter S Amenta; Mary F Barbe; Jack I Jallo
Journal:  J Neurotrauma       Date:  2011-06-01       Impact factor: 5.269

Review 5.  Post-traumatic headache.

Authors:  Steven L Linder
Journal:  Curr Pain Headache Rep       Date:  2007-10

6.  An intact facet capsular ligament modulates behavioral sensitivity and spinal glial activation produced by cervical facet joint tension.

Authors:  Beth A Winkelstein; Diana G Santos
Journal:  Spine (Phila Pa 1976)       Date:  2008-04-15       Impact factor: 3.468

Review 7.  Modulation of immune response by head injury.

Authors:  Maria Cristina Morganti-Kossmann; Laveniya Satgunaseelan; Nicole Bye; Thomas Kossmann
Journal:  Injury       Date:  2007-11-28       Impact factor: 2.586

8.  Hypertonic saline attenuates tissue loss and astrocyte hypertrophy in a model of traumatic brain injury.

Authors:  Melanie B Elliott; Jack J Jallo; Mary F Barbe; Ronald F Tuma
Journal:  Brain Res       Date:  2009-10-03       Impact factor: 3.252

9.  Levels of vasoactive intestinal peptide, cholecystokinin and calcitonin gene-related peptide in plasma and jejunum of rats following traumatic brain injury and underlying significance in gastrointestinal dysfunction.

Authors:  Chun-Hua Hang; Ji-Xin Shi; Jie-Shou Li; Wei Wu; Wei-Qin Li; Hong-Xia Yin
Journal:  World J Gastroenterol       Date:  2004-03-15       Impact factor: 5.742

Review 10.  Neurobehavioral sequelae of traumatic brain injury.

Authors:  Silvana Riggio; Meredith Wong
Journal:  Mt Sinai J Med       Date:  2009-04
View more
  35 in total

1.  Acute Post-Traumatic Sleep May Define Vulnerability to a Second Traumatic Brain Injury in Mice.

Authors:  Rachel K Rowe; Jordan L Harrison; Helena W Morrison; Vignesh Subbian; Sean M Murphy; Jonathan Lifshitz
Journal:  J Neurotrauma       Date:  2018-12-18       Impact factor: 5.269

Review 2.  From blast to bench: A translational mini-review of posttraumatic headache.

Authors:  Laura S Moye; Amynah A Pradhan
Journal:  J Neurosci Res       Date:  2017-02-02       Impact factor: 4.164

3.  Deficient pain modulatory systems in patients with mild traumatic brain and chronic post-traumatic headache: implications for its mechanism.

Authors:  Ruth Defrin; Miri Riabinin; Yelena Feingold; Shaul Schreiber; Chaim G Pick
Journal:  J Neurotrauma       Date:  2015-01-01       Impact factor: 5.269

4.  Trigeminal Pain Molecules, Allodynia, and Photosensitivity Are Pharmacologically and Genetically Modulated in a Model of Traumatic Brain Injury.

Authors:  Brittany V Daiutolo; Ashley Tyburski; Shannon W Clark; Melanie B Elliott
Journal:  J Neurotrauma       Date:  2015-12-17       Impact factor: 5.269

Review 5.  Modelling headache and migraine and its pharmacological manipulation.

Authors:  S E Erdener; T Dalkara
Journal:  Br J Pharmacol       Date:  2014-07-01       Impact factor: 8.739

Review 6.  Linking Traumatic Brain Injury, Sleep Disruption and Post-Traumatic Headache: a Potential Role for Glymphatic Pathway Dysfunction.

Authors:  Juan Piantino; Miranda M Lim; Craig D Newgard; Jeffrey Iliff
Journal:  Curr Pain Headache Rep       Date:  2019-07-29

7.  Trigeminal neuroplasticity underlies allodynia in a preclinical model of mild closed head traumatic brain injury (cTBI).

Authors:  Golam Mustafa; Jiamei Hou; Shigeharu Tsuda; Rachel Nelson; Ankita Sinharoy; Zachary Wilkie; Rahul Pandey; Robert M Caudle; John K Neubert; Floyd J Thompson; Prodip Bose
Journal:  Neuropharmacology       Date:  2016-03-10       Impact factor: 5.250

Review 8.  Post-Traumatic Headache Therapy in the Athlete.

Authors:  Tad Seifert
Journal:  Curr Pain Headache Rep       Date:  2016-06

9.  The development of a mouse model of mTBI-induced post-traumatic migraine, and identification of the delta opioid receptor as a novel therapeutic target.

Authors:  Laura S Moye; Madeline L Novack; Alycia F Tipton; Harish Krishnan; Subhash C Pandey; Amynah Aa Pradhan
Journal:  Cephalalgia       Date:  2018-05-17       Impact factor: 6.292

10.  sec-Butylpropylacetamide (SPD) has antimigraine properties.

Authors:  Dan Kaufmann; Emily A Bates; Boris Yagen; Meir Bialer; Gerald H Saunders; Karen Wilcox; H Steve White; K C Brennan
Journal:  Cephalalgia       Date:  2015-11-13       Impact factor: 6.292

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.